Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.
Autoimmune diseases are characterized by aberrant immune responses against healthy cells and tissues. However, the exact mechanisms underlying the development of these conditions remain unknown. CD4+CD25+ regulatory T cells (Tregs) are a subset of mature T cells which have an important role in maintaining immune homeostasis and preventing autoimmune diseases. Forkhead box p3 (Foxp3), a member of the fork head transcription factor family, is recognized as a marker of CD4+CD25+ Tregs. The decreased number and/or function of CD4+CD25+ Tregs in peripheral blood and related tissues has been demonstrated in systemic lupus erythematosus, systemic sclerosis, and other autoimmune diseases, which are at least partially regulated by epigenetic mechanisms. Epigenetics refers to the study of potentially heritable alterations in gene expression without underlying changes of the nucleotide sequence, mainly including DNA methylation, histone modification, and microRNAs (miRNAs). For example, DNA methylation status of CpG islands on the Foxp3 gene, which may be affected by normal aging and regulated by environmental factors, plays an important role in modulating the homeostasis of Foxp3 expression in Tregs. Foxp3 gene in Tregs also shows distinct acetylation and trimethylation levels of histone H3 and H4 when compared with effector T cells, leading to an open chromatin structure. MicroRNAs such as miR-155, miR-126, and miR-10a also exert an important influence on the differentiation, development, and immunological functions of Tregs. Aberrant epigenetic modifications affecting Foxp3 and other key genes in Tregs contribute to disease activity and tissue inflammation in autoimmune diseases, which holds great potential for providing novel targets for epigenetic therapies. Advances in research into the epigenetic regulation of CD4+CD25+ Tregs may also lead to the identification of new epigenetic biomarkers for diagnosis and prognosis.
Department of Dermatology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenetics, Changsha, China.|Department of Dermatology, Hunan Province Children's Hospital, Changsha, China.
Ye
Y
Shu
Department of Cardiovascular Surgery, Xiangya Hospital, Central South University, Changsha, China.
Qinghua
Q
Hu
Department of Dermatology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenetics, Changsha, China.
Hai
H
Long
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA.
Christopher
C
Chang
Department of Dermatology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenetics, Changsha, China.
Qianjin
Q
Lu
Department of Dermatology, The Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenetics, Changsha, China. xiaorong65@aliyun.com.
Rong
R
Xiao
D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology*; D044127:Epigenesis, Genetic / Q000276:immunology*; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
Autoimmune diseases; DNA methylation; Epigenetic mechanism; Foxp3; Histone deacetylation; MicroRNA; Tregs
Br J Dermatol. 2010 May;162(5):1056-63
20105169
J Exp Med. 2007 Jul 9;204(7):1543-51
17591856
J Immunol. 2010 Jun 15;184(12):7257-67
20488788
Br J Dermatol. 2014 Jul;171(1):39-47
24641670
Clin Exp Rheumatol. 2014 Sep-Oct;32(5):630-9
25197969
J Clin Invest. 2003 Nov;112(9):1437-43
14597769
Eur J Dermatol. 2011 May-Jun;21(3):344-8
21680285
Clin Rheumatol. 2010 Nov;29(11):1251-8
20563617
Int J Clin Exp Med. 2015 Feb 15;8(2):1792-802
25932107
Int J Rheum Dis. 2014 Sep;17(7):790-5
25430593
Epigenetics. 2012 Dec 1;7(12):1391-402
23108258
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3432-40
25099355
J Cell Physiol. 2014 Dec;229(12):1918-25
24700487
Am J Respir Cell Mol Biol. 2015 May;52(5):641-52
25295995
Nat Genet. 2001 Jan;27(1):18-20
11137992
Neuromolecular Med. 2015 Mar;17(1):24-34
25362566
Bone Marrow Transplant. 2014 Mar;49(3):349-54
24362364
J Immunol. 2009 Mar 1;182(5):2578-82
19234151
Eur J Immunol. 2007 Sep;37(9):2378-89
17694575
Nature. 2010 Feb 11;463(7282):808-12
20072126
J Immunol. 2015 Jan 1;194(1):113-24
25452562
Diabetes. 2011 Nov;60(11):2903-13
21896932
Cell Mol Gastroenterol Hepatol. 2015 Mar 1;1(2):188-202.e4
25750932
J Biol Chem. 2012 Oct 5;287(41):34372-85
22896699
Nat Immunol. 2014 Jun;15(6):571-9
24777532
Immunol Invest. 2016;45(1):63-74
26730791
Nat Genet. 2001 Jan;27(1):20-1
11137993
J Immunol Res. 2014;2014:989434
24741640
J Allergy Clin Immunol. 2012 Jul;130(1):215-24.e7
22677046
G Ital Dermatol Venereol. 2013 Apr;148(2):197-201
23588145
Rheumatol Int. 2012 Apr;32(4):949-58
21243492
J Allergy Clin Immunol. 2014 Feb;133(2):500-10
24636474
Mod Rheumatol. 2015 Jan;25(1):90-5
24716598
Clin Immunol. 2012 May;143(2):180-7
22406048
J Allergy Clin Immunol. 2013 Feb;131(2):592-4.e1-3
23260754
Clin Immunol. 2015 Apr;157(2):166-74
25638413
Arthritis Rheumatol. 2014 Apr;66(4):874-85
24757140
J Immunol. 2009 Jan 1;182(1):259-73
19109157
Ann Rheum Dis. 2011 Aug;70(8):1475-81
21097800
Nat Genet. 2001 Jan;27(1):68-73
11138001
Autoimmunity. 2014 Nov;47(7):445-50
24829059
Biochem Biophys Res Commun. 2013 Jan 11;430(2):804-9
23201402
Clin Exp Immunol. 2014 Oct;178(1):9-19
24749771
Nat Med. 2007 Nov;13(11):1299-307
17922010
Eur J Immunol. 2013 Apr;43(4):1001-12
23436577
Eur J Dermatol. 2014 Jul-Aug;24(4):464-9
25119950
Clin Immunol. 2014 Jan;150(1):22-30
24316592
Ann Rheum Dis. 2012 Jul;71(7):1227-34
22696687
PLoS One. 2012;7(5):e36684
22629323
J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):476-81
21823008
Rheumatol Int. 2012 Sep;32(9):2731-6
21809006
Arthritis Rheumatol. 2015 May;67(5):1182-92
25604080
Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R608-20
24944246
Immunity. 2009 Jan 16;30(1):80-91
19144316
J Allergy Clin Immunol. 2010 Oct;126(4):845-852.e10
20920773
Immunol Invest. 2015;44(2):126-36
25083793
Sci Signal. 2011 Feb 01;4(158):pe4
21285410
J Neurosci. 2013 Oct 30;33(44):17350-62
24174668
Int J Rheum Dis. 2016 Jun;19(6):586-93
24467668
Arthritis Rheumatol. 2014 Nov;66(11):3083-95
25047518
J Rheumatol. 2011 Dec;38(12):2517-21
21921095
Zhonghua Yi Xue Za Zhi. 2011 Mar 8;91(9):586-90
21600126
Immunity. 2008 Jan;28(1):100-11
18199417
PLoS Genet. 2013;9(8):e1003678
23950730
Zhonghua Yi Xue Za Zhi. 2012 Feb 21;92(7):460-3
22490966
Cytokine. 2014 Aug;68(2):76-85
24845796
PLoS One. 2013;8(1):e54895
23365685
J Immunol. 2004 May 1;172(9):5213-21
15100259
Clin Immunol. 2014 Mar;151(1):29-42
24503172
J Immunol. 2015 Dec 15;195(12):5667-77
26538392
Cell Immunol. 2010;260(2):70-4
19954774
Nat Commun. 2014 Dec 22;5:5780
25531312
Dermatology. 2011;223(1):57-67
21865674
PLoS Biol. 2007 Feb;5(2):e38
17298177
J Immunol. 2015 Aug 15;195(4):1608-16
26163585
J Autoimmun. 2013 Mar;41:50-9
23490285
Ann Rheum Dis. 2015 Jun;74(6):1265-74
24562503
J Neuroimmunol. 2010 Sep 14;226(1-2):165-71
20637509
Aging Cell. 2014 Jun;13(3):441-8
24325345
J Immunol. 2010 Dec 1;185(11):6426-30
21037099
Eur J Immunol. 2014 Oct;44(10):2968-78
25042153
J Cell Mol Med. 2013 Feb;17(2):252-64
23301798
J Invest Dermatol. 2011 Sep;131(9):1853-60
21654831
Arthritis Res Ther. 2013 Feb 27;15(1):R35
23446139
Scand J Rheumatol. 2015;44(1):29-35
25205084
Int Immunopharmacol. 2015 Oct;28(2):859-65
25870037
J Cell Mol Med. 2014 Nov;18(11):2213-24
25164131
J Immunol. 2013 Aug 15;191(4):1594-605
23858035